CLINICAL_TRIALS
trial_result
· 2022-05-31
Clinical Trial Update: BI 671800 in Asthmatic Patients on Inhaled Corticosteroids [Phase 2]
Summary
Phase 2 trial update for BI 671800 in asthmatic patients on inhaled corticosteroids; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2022-05-31